On May 11, 2023 ChromaDex Corp. (NASDAQ:CDXC), a global bioscience company dedicated to healthy aging, reported that its Chief Executive Officer, Rob Fried, and Chief Financial Officer, Brianna Gerber, reported that it will be participating in the Lytham Partners Spring 2023 Investor Conference (Press release, ChromaDex, MAY 11, 2023, View Source [SID1234631496]).

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Mr. Fried and Mrs. Gerber will be participating in virtual one-on-one meetings throughout the event on Thursday, May 18, 2023.

To arrange a meeting with the ChromaDex management team, please contact Lytham Partners at 1×[email protected], or register online by clicking the link here: ChromaDex Investor Meetings – Lytham Partners.

For additional information on ChromaDex, visit www.chromadex.com.